Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of matrix metalloproteinases and aggrecanase in the synovial fluids of patients with symptomatic temporomandibular disorders.
Yoshida K, Takatsuka S, Hatada E, Nakamura H, Tanaka A, Ueki K, Nakagawa K, Okada Y, Yamamoto E, Fukuda R. Yoshida K, et al. Among authors: nakamura h. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):22-7. doi: 10.1016/j.tripleo.2005.07.013. Epub 2006 May 11. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006. PMID: 16831668
Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
Hira-Miyazawa M, Nakamura H, Hirai M, Kobayashi Y, Kitahara H, Bou-Gharios G, Kawashiri S. Hira-Miyazawa M, et al. Among authors: nakamura h. Int J Oncol. 2018 Feb;52(2):379-388. doi: 10.3892/ijo.2017.4221. Epub 2017 Dec 11. Int J Oncol. 2018. PMID: 29345283 Free PMC article.
A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone.
Hatta K, Otachi T, Sudo Y, Kuga H, Takebayashi H, Hayashi H, Ishii R, Kasuya M, Hayakawa T, Morikawa F, Hata K, Nakamura M, Usui C, Nakamura H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Among authors: nakamura m, nakamura h. Psychiatry Res. 2012 Jul 30;198(2):194-201. doi: 10.1016/j.psychres.2012.01.006. Epub 2012 Mar 13. Psychiatry Res. 2012. PMID: 22421064 Clinical Trial.
Effectiveness of second-generation antipsychotics with acute-phase schizophrenia.
Hatta K, Sato K, Hamakawa H, Takebayashi H, Kimura N, Ochi S, Sudo Y, Asukai N, Nakamura H, Usui C, Kawabata T, Hirata T, Sawa Y. Hatta K, et al. Among authors: nakamura h. Schizophr Res. 2009 Aug;113(1):49-55. doi: 10.1016/j.schres.2009.05.030. Epub 2009 Jun 24. Schizophr Res. 2009. PMID: 19553086 Clinical Trial.
Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia.
Hatta K, Otachi T, Sudo Y, Hayakawa T, Ashizawa Y, Takebayashi H, Hayashi N, Hamakawa H, Ito S, Nakase R, Usui C, Nakamura H, Hirata T, Sawa Y; JAST Study Group. Hatta K, et al. Among authors: nakamura h. Schizophr Res. 2011 May;128(1-3):127-35. doi: 10.1016/j.schres.2011.02.011. Epub 2011 Mar 21. Schizophr Res. 2011. PMID: 21420283 Clinical Trial.
10,651 results
You have reached the last available page of results. Please see the User Guide for more information.